211 related articles for article (PubMed ID: 10699300)
1. The preparation and evaluation of poly(epsilon-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug.
Hombreiro Pérez M; Zinutti C; Lamprecht A; Ubrich N; Astier A; Hoffman M; Bodmeier R; Maincent P
J Control Release; 2000 Apr; 65(3):429-38. PubMed ID: 10699300
[TBL] [Abstract][Full Text] [Related]
2. Biodegradable microparticles as a two-drug controlled release formulation: a potential treatment of inflammatory bowel disease.
Lamprecht A; Rodero Torres H; Schäfer U; Lehr CM
J Control Release; 2000 Dec; 69(3):445-54. PubMed ID: 11102684
[TBL] [Abstract][Full Text] [Related]
3. Poly (epsilon-caprolactone) microparticles containing Levobunolol HCl prepared by a multiple emulsion (W/O/W) solvent evaporation technique: effects of some formulation parameters on microparticle characteristics.
Karataş A; Sonakin O; Kiliçarslan M; Baykara T
J Microencapsul; 2009 Feb; 26(1):63-74. PubMed ID: 18608798
[TBL] [Abstract][Full Text] [Related]
4. Effects of crystalline microstructure on drug release behavior of poly(epsilon-caprolactone) microspheres.
Jeong JC; Lee J; Cho K
J Control Release; 2003 Oct; 92(3):249-58. PubMed ID: 14568406
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of propranolol hydrochloride nanoparticles: a comparative study.
Ubrich N; Bouillot P; Pellerin C; Hoffman M; Maincent P
J Control Release; 2004 Jun; 97(2):291-300. PubMed ID: 15196756
[TBL] [Abstract][Full Text] [Related]
6. Non-degradable microparticles containing a hydrophilic and/or a lipophilic drug: preparation, characterization and drug release modeling.
Hombreiro-Pérez M; Siepmann J; Zinutti C; Lamprecht A; Ubrich N; Hoffman M; Bodmeier R; Maincent P
J Control Release; 2003 Mar; 88(3):413-28. PubMed ID: 12644367
[TBL] [Abstract][Full Text] [Related]
7. Disodium norcantharidate loaded poly(epsilon-caprolactone) microspheres I. Preparation and evaluation.
Wang S; Guo S; Cheng L
Int J Pharm; 2008 Feb; 350(1-2):130-7. PubMed ID: 17900833
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterizations, in vitro and in vivo evaluation of Etoricoxib-loaded Poly (Caprolactone) microparticles--a potential Intra-articular drug delivery system for the treatment of Osteoarthritis.
Arunkumar P; Indulekha S; Vijayalakshmi S; Srivastava R
J Biomater Sci Polym Ed; 2016; 27(4):303-16. PubMed ID: 26689653
[TBL] [Abstract][Full Text] [Related]
9. Nifedipine molecular dispersion in microparticles of ammonio methacrylate copolymer and ethylcellulose binary blends for controlled drug delivery: effect of matrix composition.
Huang J; Wigent RJ; Schwartz JB
Drug Dev Ind Pharm; 2006; 32(10):1185-97. PubMed ID: 17090441
[TBL] [Abstract][Full Text] [Related]
10. Influence of polymer blends on the characterization of gliclazide--encapsulated into poly (ε-caprolactone) microparticles.
Barakat NS; Shazly GA; Almedany AH
Drug Dev Ind Pharm; 2013 Feb; 39(2):352-62. PubMed ID: 22540378
[TBL] [Abstract][Full Text] [Related]
11. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
[TBL] [Abstract][Full Text] [Related]
12. Encapsulation of water-soluble drugs by an o/o/o-solvent extraction microencapsulation method.
Elkharraz K; Ahmed AR; Dashevsky A; Bodmeier R
Int J Pharm; 2011 May; 409(1-2):89-95. PubMed ID: 21356287
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of novel poly(sebacic anhydride-co-Pluronic F68/F127) biopolymeric microspheres for the controlled release of nifedipine.
Shelke NB; Aminabhavi TM
Int J Pharm; 2007 Dec; 345(1-2):51-8. PubMed ID: 17616283
[TBL] [Abstract][Full Text] [Related]
14. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
Xu H; Zhong H; Liu M; Xu C; Gao Y
Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
[TBL] [Abstract][Full Text] [Related]
15. Adapalene-loaded poly(ε-caprolactone) microparticles: Physicochemical characterization and in vitro penetration by photoacoustic spectroscopy.
Nadal JM; Dos Anjos Camargo G; Novatski A; Macenhan WR; Dias DT; Barboza FM; Lyra A; Roik JR; Padilha de Paula J; Somer A; Farago PV
PLoS One; 2019; 14(3):e0213625. PubMed ID: 30897170
[TBL] [Abstract][Full Text] [Related]
16. Full factorial design optimization of anti-inflammatory drug release by PCL-PEG-PCL microspheres.
Azouz L; Dahmoune F; Rezgui F; G'Sell C
Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():412-9. PubMed ID: 26478328
[TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization and in vitro release properties of ibuprofen-loaded microspheres based on polylactide, poly(epsilon-caprolactone) and their copolymers.
Zhu KJ; Li Y; Jiang HL; Yasuda H; Ichimaru A; Yamamoto K; Lecomte P; Jerome R
J Microencapsul; 2005 Feb; 22(1):25-36. PubMed ID: 16019888
[TBL] [Abstract][Full Text] [Related]
18. Effect of the microencapsulation of nanoparticles on the reduction of burst release.
Hasan AS; Socha M; Lamprecht A; Ghazouani FE; Sapin A; Hoffman M; Maincent P; Ubrich N
Int J Pharm; 2007 Nov; 344(1-2):53-61. PubMed ID: 17643878
[TBL] [Abstract][Full Text] [Related]
19. Chitosan and poly(methyl vinyl ether-co-maleic anhydride) microparticles as nasal sustained delivery systems.
Cerchiara T; Luppi B; Chidichimo G; Bigucci F; Zecchi V
Eur J Pharm Biopharm; 2005 Oct; 61(3):195-200. PubMed ID: 16006107
[TBL] [Abstract][Full Text] [Related]
20. Preparation of 3,4-diaminopyridine microparticles by solvent-evaporation methods.
Gibaud S; Bonneville A; Astier A
Int J Pharm; 2002 Aug; 242(1-2):197-201. PubMed ID: 12176246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
